DOD-CDMRP: Neurofibromatosis Research Program - Clinical Consortium Award.

Support a consortium that will conceive, develop, and conduct collaborative clinical evaluations focused on NF1 and NF2 therapeutic interventions. Open to any group of institutions with a demonstrated history of collaborative NF research. All applications must include letters of intent for conducting a minimum of four clinical trials; at least one NF1- and one NF2-focused study must be initiated within the first year of the award. Max funding $9,000,000 over max 5 years.